{{Drugbox
| Watchedfields = changed
| verifiedrevid = 470637441
| IUPAC_name = 5-{2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl}-6-chloro-1,3-dihydro-2''H''-indol-2-one
| image = Ziprasidone.svg
| width = 275
| image2 = Ziprasidone ball-and-stick model.png

<!--Clinical data-->
| tradename = Geodon, Zeldox, Zipwell
| Drugs.com = {{drugs.com|monograph|ziprasidone}}
| MedlinePlus = a699062
| licence_US = Ziprasidone
| pregnancy_AU = B3
| pregnancy_US = C
| legal_AU = S4
| legal_US = Rx-only
| routes_of_administration = [[口服給藥|口服]]([[膠囊劑|膠囊劑]])、[[肌肉注射|IM]]

<!--Pharmacokinetic data-->
| bioavailability = 60% (口服)<ref name=2011rev>{{cite journal|last1=Stahl|last2=Chiara Mattei|last3=Maria Paola Rapagnani|title=Ziprasidone Hydrocloride: What Role in the Management of Schizophrenia?|journal=Journal of Central Nervous System Disease|date=February 2011|pages=1-16|pmid=23861634|pmc=3663608|doi=10.4137/JCNSD.S4138|volume=3}}</ref>
<br />100% (IM)

| metabolism = [[肝|肝]]的([[醛糖還原酶|醛糖還原酶]])
| elimination_half-life = 7 to 10 小時<ref name=2007rev>{{cite journal|title=Ziprasidone in the treatment of mania in bipolar disorder|journal=Neuropsychiatr Dis Treat|date=December 2007|volume=3|issue=6|pages=823–34|pmid=19300617|pmc=2656324|last1=Nicolson|first1= SE |last2=Nemeroff |first2=CB}}</ref>

| excretion = 尿液及糞便

<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 146939-27-7
| ATC_prefix = N05
| ATC_suffix = AE04
| PubChem = 60854
| IUPHAR_ligand = 59
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB00246
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 54841
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 6UKA5VEJ6X
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D08687
| ChEBI_Ref = {{ebicite|correct|EBI}}
| ChEBI = 10119
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 708

<!--Chemical data-->
| C=21 | H=21 | Cl=1 | N=4 | O=1 | S=1
| molecular_weight = 412.936 g/mol
| SMILES = O=C1Cc2c(N1)cc(Cl)c(c2)CCN3CCN(CC3)c4nsc5ccccc45
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C21H21ClN4OS/c22-17-13-18-15(12-20(27)23-18)11-14(17)5-6-25-7-9-26(10-8-25)21-16-3-1-2-4-19(16)28-24-21/h1-4,11,13H,5-10,12H2,(H,23,27)
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = MVWVFYHBGMAFLY-UHFFFAOYSA-N
}}
{{medical}}
'''齊拉西酮'''（Ziprasidone），以 Geodon 等品牌上市，是一種{{le|非典型抗精神病藥|Atypical antipsychotic}}(AAP；SGAs)，用於治療[[精神分裂症|精神分裂症]]以及伴有[[躁鬱症|躁鬱症]]相關的急性[[狂躁|狂躁]]症與{{le|混合激動狀態|Mixed affective state|激越性抑鬱症}}。<ref>{{cite web|url=https://www.drugs.com/pro/geodon.html|website=Drugs.com|accessdate=June 4, 2015|title=Geodon}}</ref>其立即釋放藥性的[[肌肉注射|肌肉注射]]形式被批准用於精神分裂症患者的急性{{le|精神運動性激越|Psychomotor agitation}}症。齊拉西酮也可用於[[抑鬱_(情緒)|情緒抑鬱]]症狀、{{le|躁鬱症的治療|Treatment of bipolar disorder}}，與[[創傷後壓力症候群|創傷後壓力症候群]]（PTSD）等症狀的{{le|藥品仿單標示外使用|Off-label use}}之治療藥物。<ref>{{cite web|last1=Poole|first1=Jerod|title=Geodon Approved Uses|url=http://www.crazymeds.us/pmwiki/pmwiki.php/Meds/GeodonApprovedAndOffLabelUses|website=CrazyMeds|accessdate=June 19, 2015}}</ref>

齊拉西酮的[[口服給藥|口服給藥]]是以{{le|鹽酸鹽|Hydrochloride}}，齊拉西酮鹽酸鹽(ziprasidone hydrochloride)等的藥形。另一方面，[[肌肉注射|肌肉注射]](IM)給藥是以[[甲磺酸酯|甲磺]]酸鹽、齊拉西酮甲磺酸鹽三水合物(ziprasidone mesylate trihydrate；三水合物甲磺酸齊拉西酮)等的藥形，並以[[冷凍乾燥|凍乾]]粉末形式提供。齊拉西酮於2001年2月5日在美國獲得批准上市。<ref>http://www.prnewswire.com/news-releases/pfizer-to-launch-zeldox-in-9-european-union-countries-beginning-next-month-76154202.html</ref><ref>http://www.accessdata.fda.gov/drugsatfda_docs/nda/2001/20-825_geodan.cfm</ref>

{{TOC limit|3}}

==註釋==
{{Reflist|30em}}

==延伸閱讀==
{{refbegin}}
* {{cite book | author = David Taylor | title = Schizophrenia in Focus | url = https://books.google.com/books?id=CyEUUKDScOIC&pg=PA123 | accessdate = May 13, 2012 | year = 2006 | publisher = Pharmaceutical Press | isbn = 978-0-85369-607-0 | page = 123}}
{{refend}}

==參見==
*[[妥瑞症|妥瑞症]]

==外部連結==
*[https://medlineplus.gov/druginfo/meds/a699062.html Ziprasidone: MedlinePlus Drug Information]

{{Antipsychotics}}
{{Mood stabilizers}}
{{Navboxes
| title = [[藥物效應動力學|藥物效應動力學]]
| titlestyle = background:#ccccff
| list1 = 
{{Adrenergic receptor modulators}}
{{tsl|en|template:Dopamine receptor modulators}}
[[template:Histaminergics|template:Histaminergics]]
{{tsl|en|template:Monoamine reuptake inhibitors}}
{{Serotonergics}}
}}

[[Category:抗抑鬱藥物|Category:抗抑鬱藥物]]
[[Category:非典型抗精神病藥|Category:非典型抗精神病藥]]
[[Category:苯並異噻唑|Category:苯並異噻唑]]
[[Category:多巴胺拮抗藥|Category:多巴胺拮抗藥]]
[[Category:二氢吲哚|Category:二氢吲哚]]
[[Category:内酰胺|Category:内酰胺]]
[[Category:情緒穩定劑|Category:情緒穩定劑]]
[[Category:輝瑞產品|Category:輝瑞產品]]
[[Category:哌嗪|Category:哌嗪]]
[[Category:血清素拮抗剂|Category:血清素拮抗剂]]
[[Category:羥吲哚|Category:羥吲哚]]
[[Category:氯代芳烴|Category:氯代芳烴]]